Tingting Liu, Xiaoxin Liang, Wei Liu, Shuai Yang, Tao Cui, Fei Yan, Zhenzhou Li
{"title":"iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma.","authors":"Tingting Liu, Xiaoxin Liang, Wei Liu, Shuai Yang, Tao Cui, Fei Yan, Zhenzhou Li","doi":"10.2147/IJN.S494151","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Osteosarcoma is the most common primary malignant tumor of the bone. However, there is a lack of effective means for early diagnosis due to the heterogeneity of tumors and the complexity of tumor microenvironment. αvβ3 integrin, a crucial role in the growth and spread of tumors, is not only an effective biomarker for cancer angiogenesis, but also highly expressed in many tumor cells. Here, we selected it as the imaging target and fabricated iRGD-sGVs acoustic probe for the early-stage diagnosis of osteosarcoma.</p><p><strong>Materials and methods: </strong>Biological nanoscale gas vesicles (sGVs) were extracted from <i>Serratia 39006</i>. Their morphology was analyzed with phase contrast and transmission electron microscopes. Particle size and zeta potential were measured by a Zetasizer. iRGD-targeted molecular probes (iRGD-sGVs) were prepared by coupling iRGD to sGVs via Mal-PEG2000-NHS. Targeting efficiency of iRGD-sGVs was evaluated using flow cytometry and confocal microscopy on endothelial and K7M2 osteosarcoma cells. In vivo contrast-enhanced ultrasound imaging of iRGD-sGVs was performed in osteosarcoma-bearing mice, and the expression of a<sub>v</sub>β<sub>3</sub> in osteosarcoma was detected through immunofluorescence staining assay. Biocompatibility of sGVs was assessed by hemolysis tests, CCK8 cytotoxicity assays, blood biochemical tests, and HE staining.</p><p><strong>Results: </strong>sGVs from <i>Serratia</i>.39006 have smaller particle size (about 160 nm). Our in vitro and in vivo experiments showed the specifically binding ability of iRGD-sGVs to both vascular endothelial cells and tumor cells, producing the stronger and longer acoustic signals in tumors in comparison with the control probe. Immunofluorescence staining results indicated iRGD-sGVs were co-localized with highly expressed αvβ3 in tumor vasculature and osteosarcoma cells. Biocompatibility analysis showed no significant cytotoxicity of iRGD-sGVs to mice.</p><p><strong>Conclusion: </strong>Our study provides a new strategy for early diagnosis of osteosarcoma.</p>","PeriodicalId":14084,"journal":{"name":"International Journal of Nanomedicine","volume":"20 ","pages":"791-805"},"PeriodicalIF":6.6000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11760272/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nanomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJN.S494151","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"NANOSCIENCE & NANOTECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Osteosarcoma is the most common primary malignant tumor of the bone. However, there is a lack of effective means for early diagnosis due to the heterogeneity of tumors and the complexity of tumor microenvironment. αvβ3 integrin, a crucial role in the growth and spread of tumors, is not only an effective biomarker for cancer angiogenesis, but also highly expressed in many tumor cells. Here, we selected it as the imaging target and fabricated iRGD-sGVs acoustic probe for the early-stage diagnosis of osteosarcoma.
Materials and methods: Biological nanoscale gas vesicles (sGVs) were extracted from Serratia 39006. Their morphology was analyzed with phase contrast and transmission electron microscopes. Particle size and zeta potential were measured by a Zetasizer. iRGD-targeted molecular probes (iRGD-sGVs) were prepared by coupling iRGD to sGVs via Mal-PEG2000-NHS. Targeting efficiency of iRGD-sGVs was evaluated using flow cytometry and confocal microscopy on endothelial and K7M2 osteosarcoma cells. In vivo contrast-enhanced ultrasound imaging of iRGD-sGVs was performed in osteosarcoma-bearing mice, and the expression of avβ3 in osteosarcoma was detected through immunofluorescence staining assay. Biocompatibility of sGVs was assessed by hemolysis tests, CCK8 cytotoxicity assays, blood biochemical tests, and HE staining.
Results: sGVs from Serratia.39006 have smaller particle size (about 160 nm). Our in vitro and in vivo experiments showed the specifically binding ability of iRGD-sGVs to both vascular endothelial cells and tumor cells, producing the stronger and longer acoustic signals in tumors in comparison with the control probe. Immunofluorescence staining results indicated iRGD-sGVs were co-localized with highly expressed αvβ3 in tumor vasculature and osteosarcoma cells. Biocompatibility analysis showed no significant cytotoxicity of iRGD-sGVs to mice.
Conclusion: Our study provides a new strategy for early diagnosis of osteosarcoma.
期刊介绍：
The International Journal of Nanomedicine is a globally recognized journal that focuses on the applications of nanotechnology in the biomedical field. It is a peer-reviewed and open-access publication that covers diverse aspects of this rapidly evolving research area.
With its strong emphasis on the clinical potential of nanoparticles in disease diagnostics, prevention, and treatment, the journal aims to showcase cutting-edge research and development in the field.
Starting from now, the International Journal of Nanomedicine will not accept meta-analyses for publication.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
